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Abstract. 
 
Protein methylation is a posttranslational 
modification that can potentially regulate signal trans-
duction pathways in a similar manner as protein phos-
phorylation. The role of protein methylation in NGF 
signaling was examined by metabolic labeling of PC12 
 
cell proteins with 
 
l
 
-[methyl-
 
3
 
H]methionine and by in 
vitro labeling of cell proteins with 
 
l
 
-[methyl-
 
3
 
H]S-ade-
nosylmethionine. Effects of NGF were detected within 
15 min. Methyl-labeled proteins were resolved by one 
and two dimensional SDS-PAGE. NGF affected the 
methylation of several 68–60-kD proteins (pI 5.8–6.4) 
and 50-kD proteins (isoelectric point pH 6.7–6.8 and 
5.8–6.2). Several NGF-induced changes in methylation 
increased over several hours and through 4 d. More-
over, methyl labeling of several specific proteins was 
only detected after NGF treatment, but not in non-
treated controls. The effects of NGF on protein methy-
lation were NGF specific since they were not observed 
with EGF or insulin. A requirement for protein methy-
lation for neurite outgrowth was substantiated with ei-
ther of two methylation inhibitors: dihydroxycyclopen-
tenyl adenine (DHCA) and homocysteine. DHCA, the 
more potent of the two, markedly inhibits protein 
methylation and neurite outgrowth without affecting 
cell growth, NGF-induced survival, cell flattening, or 
several protein phosphorylations that are associated 
with early signaling events. Removal of DHCA leads to 
rapid protein methylation of several proteins and con-
current neurite outgrowth. The results indicate that 
NGF regulates the methylation of several specific pro-
teins and that protein methylation is involved in neurite 
outgrowth from PC12 cells.
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1. 
 
Abbreviations used in this paper
 
: DHCA, 9-(
 
trans
 
-2
 
9
 
, 
 
trans
 
-3
 
9
 
-dihy-
droxycyclopent-4
 
9
 
-enyl)-adenine; ERK, extracellular signal-regulated ki-
nase; PAS, protein-A-Sepharose; 2D two dimensional; PI, phosphoinosi-
tide; SAHcy, S-adenosylhomocysteine; SAHH, S-adenosylhomocysteine
hydrolase; SAM, S-adenosylmethionine; Trk, tyrosine kinase receptor.
 
P
 
rotein
 
 methylation is a posttranslational modifica-
tion that may be used to regulate signal transduc-
tion and differentiation pathways by mechanisms
that are analogous to regulation by protein phosphoryla-
tion (Hrycyna and Clarke, 1993; Rando, 1996). Although a
specific role for protein methylation in prokaryote chemo-
taxis is well established (Shapiro et al., 1995), possible
roles for protein methylation in eukaryotic signaling mech-
anisms have not been extensively explored. Protein car-
boxyl methylations are reversible, and regulatory roles for
carboxyl methylation have been proposed for chemoat-
tractant responses in neutrophils (Philips et al., 1993,
1995), insulin secretion from pancreatic islets (Metz et al.,
1993), and photoreceptor signal transduction (Parish et al.,
1995). Among signaling proteins that are known to be car-
boxyl methylated are the Ras and Rho family of small
G-proteins (Hrycyna and Clarke, 1993; Rando, 1996), 
 
g
 
subunits of heterotrimeric G-proteins (Philips et al., 1993;
Rando, 1996), and the catalytic subunit of protein phos-
phatase 2A (Lee and Stock, 1993; Favre et al., 1994; Xie
and Clarke, 1994). Protein phosphatase 2A is also demeth-
ylated by a specific protein carboxyl methylesterase (Lee
et al., 1996). Many proteins are known to be N-methylated
at arginine, lysine, or histidine residues including cytoskel-
etal proteins (actin and myosin), nuclear proteins (nucleo-
lin, fibrillarin, histones, heterogeneous nuclear RNPs), the
multifunctional calcium binding protein, calmodulin, and
FGF-2. The physiological functions of methylation, how-
ever, remain largely unknown. Moreover, potential mech-
anisms for regulating protein methylation within growth
factor signaling pathways remain to be explored.
 
Methylation pathways use S-adenosylmethionine (SAM)
 
1
 
as the universal methyl donor for methyltransferase-cata-
lyzed methylation of proteins and other methyl acceptors.
The role of methylation in NGF signal transduction was
previously studied using high concentrations (millimolar)
of inhibitors of methyltransferases that use SAM (Seeley
et al., 1984; Kujubu et al., 1993). These attempts to exam-
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ine the role of methylation in cell signaling were somewhat
compromised by the lack of specific, nontoxic inhibitors of
methylation. In addition to the methylated acceptor, S-adeno-
sylhomocysteine (SAHcy) is a product of all methyltrans-
ferase reactions. SAHcy is a strong competitive inhibitor
of SAM (Hildeshein et al., 1972) and is normally removed
by hydrolysis in a reversible reaction (De la Haba and Can-
toni, 1959) catalyzed by S-adenosylhomocysteine hydro-
lase (SAHH). Thus, inhibition of SAHH offers an alterna-
tive means to inhibit methyltransferases. This approach
was used in the present work to study protein methylation
during NGF signaling. The crucial role of SAHH and
methylation in development is evident from the nonagouti
(a
 
x
 
) mutation. The lethality of this mutation is due to a de-
letion of the SAHH gene, and embryonic development is
arrested in the preimplantation blastula stage (Miller et
al., 1994).
The PC12 clonal cell line was used to examine the role
of protein methylation in NGF signal transduction. PC12
cells are derived from a rat pheochromocytoma and serve
as a model of neuronal differentiation. When exposed to
NGF, PC12 cells assume many of the features of sympa-
thetic neurons including cell cycle arrest, survival in se-
rum-free medium, and elaboration of long neurites (Greene
and Tischler, 1976; Tischler and Greene, 1978). Moreover,
PC12 cells also respond to other growth factors. For exam-
ple, in the presence EGF, PC12 cells do not differentiate
into neuronlike cells, but do increase their mitotic rate
(Huff and Guroff, 1981). Thus, PC12 cells are useful to
study specific growth factor signaling mechanisms. The
specific signaling events and proteins involved in neurite
outgrowth have not been fully elucidated. For example,
NGF and EGF both activate several signaling proteins in-
cluding phospholipase C, phosphoinositide (PI)3-kinase,
extracellular signal–related kinase (ERKs) (MAP ki-
nases), and Ras (Kaplan and Stephens, 1994; Marshall,
1995). However, NGF, but not EGF, stimulates neurite
outgrowth in PC12 cells. One hypothesis for the specificity
of NGF actions involves kinetic differences in the activa-
tion of both Ras and ERK (Marshall, 1995). NGF stimula-
tion of PC12 cells results in prolonged activation of both
Ras and ERK activity, while EGF causes a transient rise
and fall in Ras and ERK activities (Qui and Green, 1992).
Specificity may also arise from NGF-specific signaling
pathways that are not activated by EGF and other mito-
gens (Chao, 1992; Kaplan and Stephens, 1994; Peng et al.,
1995). The results reported here indicate that signaling
pathways involving protein methylation may contribute to
NGF specificity.
Previous studies by Seeley et al. (1984) have implied
that methylation is necessary for neurite outgrowth in
PC12 cells. Kujubu et al. (1993) and Haklai et al. (1993) re-
ported that methylation of small G-proteins is regulated
by NGF in PC12 cells. Najbauer and Aswad (1990) have
also characterized several methyl-arginine containing pro-
teins in PC12 cells. The effects of NGF on protein meth-
ylation and the effect of inhibition of protein methylation
on neurite outgrowth are, however, incompletely charac-
terized and have been difficult to interpret due to the lack
of specificity of the methylation inhibitors used in previous
studies. The present work extends previous findings by ex-
amining the methylation of specific cellular proteins and
 
neurite outgrowth before and after inhibition of the pro-
tein methylation pathway. 9-(
 
trans
 
-2
 
9
 
,
 
 trans
 
-3
 
9
 
-dihydroxy-
cyclopent-4-enyl)-adenine (DHCA), a specific, mechanism-
based inhibitor of SAHH, inhibits protein methylation and
greatly decreases neurite outgrowth. The results indicate
that NGF, but not EGF or insulin, regulates the methyla-
tion of several specific proteins and that protein methyla-
tion is required for neurite outgrowth from PC12 cells.
 
Materials and Methods
 
Reagents
 
NGF was purified from male mouse submaxillary glands as described pre-
viously (Mobley et al., 1976). Insulin, 
 
l
 
-homocysteine thiolactone, aniso-
mycin, leupeptin, PMSF, aprotinin, and monoclonal phosphotyrosine anti-
body (clone PT-66) were purchased from Sigma Chemical Co. (St. Louis,
MO). Homocysteine was prepared by incubating 
 
l
 
-homocysteine thiolac-
tone with 40 mM NaOH at 37
 
8
 
C for 30 min. EGF was obtained from Up-
state Biotechnology Inc. (Lake Placid, NY). DHCA (kindly provided by
R.T. Borchardt, University of Kansas, Lawrence, KS) was prepared as 1
and 100 mM stock solutions in DMSO. Erythro-9-(2-hydroxy-3-nonyl) ad-
enine was kindly provided by D. Porter (Burroughs Wellcome, Research
Triangle Park, NC). 
 
l
 
-[methyl-
 
3
 
H]methionine (71.4 Ci/mmol), 
 
l
 
-[methyl-
 
3
 
H]SAM (70 Ci/mmol), [
 
14
 
C]adenosine (59.8 mCi/mmol), and carrier-free
[
 
32
 
P]orthophosphate were purchased from Dupont-NEN (Boston, MA).
 
125
 
I-donkey anti–rabbit IgG was purchased from Amersham Corp. (Ar-
lington Heights, IL). Protein A–Sepharose (PAS) and ampholines were
obtained from Pharmacia Fine Chemicals (Piscataway, NJ). Donor horse
serum and fetal bovine serum were from JRH Biosciences (Lenaxa, KS).
Cell culture medium, penicillin, and streptomycin were obtained from
Gibco Laboratories (Grand Island, NY). Restriction endonuclease MspI
was from New England Biolabs Inc. (Beverly, MA), and nuclease P1 from
United States Biochemical Corp. (Cleveland, OH).
 
Cell Culture and Bioassays
 
Stock cultures of PC12 cells were grown on collagen-coated tissue culture
dishes (Falcon Plastics, Cockeysville, MD) in RPMI-1640 medium supple-
mented with 10% heat-inactivated horse serum and 5% fetal bovine se-
rum at 35
 
8
 
C and 7.5% CO
 
2
 
, as previously described (Greene et al., 1987).
For neurite outgrowth studies, PC12 cells (3–5 
 
3
 
 10
 
5
 
 cells) were plated
onto collagen-coated 35-mm plastic tissue culture dishes and cultured in
RPMI-1640 medium containing 1% heat-inactivated horse serum and 50
ng/ml NGF. Neurites 
 
.
 
20 
 
m
 
m were counted as neurite-bearing cells. At
least 100 cells from each experimental condition were scored from ran-
domly chosen fields.
For the study of proliferation and survival in the presence and absence
of DHCA, naive PC12 cells were plated on collagen-coated, 24-well tissue
culture dishes at a density of 10
 
5
 
 cells per well. 1 d after plating, cells were
washed three times in RPMI-1640 medium to remove serum and then
placed either in complete medium (RPMI plus 10% horse serum and 5%
fetal bovine serum), in RPMI plus 50 ng/ml NGF, or in RPMI alone.
Where indicated, 1 
 
m
 
M DHCA was included in the culture medium. The
number of viable cells was determined by counting intact nuclei using a
hemacytometer (Soto and Sonnenschein, 1985) immediately after washing
the cultures with RPMI at time intervals of 1, 3, and 5 d later.
For the study of neurite regeneration, PC12 cells were treated with
NGF for 7–14 d. NGF was then thoroughly washed away from the cells,
and the cells were detached from the culture dish by trituration. Cells
were then replated in the presence or absence of NGF, and neurite out-
growth was scored 24 h later.
 
Metabolic Radiolabeling of Proteins
 
To assess endogenous protein methylation under various experimental
conditions, PC12 cells were cultured in 1% horse serum for at least 16 h
before metabolic radiolabeling for 6 h with 100 
 
m
 
Ci/ml 
 
l
 
-[methyl-
 
3
 
H]me-
thionine in the presence of 10 
 
m
 
M anisomycin at 35
 
8
 
C in a CO
 
2
 
 incubator.
The methionine/cysteine content of RPMI-1640 was reduced by 80% dur-
ing the labeling period. Growth factors (NGF, EGF, or insulin) and/or 1
 
m
 
M DHCA were added for the indicated times. At the conclusion of the
labeling period, cells were washed three times with 1 ml of PBS (35
 
8
 
C), 
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harvested in 200 
 
m
 
l SDS-PAGE lysis buffer, and held in a boiling water
bath for 5 min. Total radiolabeled protein in each lysate was determined
by TCA precipitation and liquid scintillation spectrometry. The averages
of the determinations are given under Results as the means 
 
6
 
 SEM. Ali-
quots of each cell lysate containing equal TCA-precipitable counts per
minute were subjected to SDS-PAGE as described below. For analysis of
protein methylation by two-dimensional (2D) IEF 
 
3 
 
SDS-PAGE, the cells
were harvested in IEF lysis buffer (Aletta and Greene, 1987) without
heating the sample.
To assess changes in protein phosphorylation, PC12 cell proteins were
metabolically radiolabeled as previously described (Aletta, 1996) in a
Hepes-buffered Krebs-Ringer solution containing 0.1% 
 
d
 
-glucose. When
the effect of DHCA was examined, the drug was added to cultures 30 min
before addition of the radioisotope. The labeling was carried out with 50
 
m
 
Ci/ml [
 
32
 
P]orthophosphate at 35
 
8
 
C in room air for 2 h. At the end of the
labeling period, cells were washed three times with 1 ml of PBS (35
 
8
 
C),
harvested in SDS-PAGE lysis buffer, and held in a boiling water bath for
5 min. Total radiolabeled protein in each lysate was determined by TCA
precipitation and liquid scintillation spectometry.
 
In Vitro Protein Methylation
 
To measure protein methylation in subcellular fractions, cells were
washed three times in PBS (4
 
8
 
C) and harvested by scraping with a rubber
policeman in ice-cold homogenization buffer (100 mM Tris, pH 8.0, 1 mM
EDTA, 2 
 
m
 
M PMSF, and 10 
 
m
 
g/ml leupeptin). After homogenization at
4
 
8
 
C in a Dounce homogenizer, the homogenates were centrifuged at 4
 
8
 
C
for 10 min at 500 
 
g
 
 to obtain a crude nuclear fraction. The supernatant was
centrifuged at 20,000 
 
g
 
 for 5 min at 4
 
8
 
C. The resulting supernatant was
centrifuged at 100,000 
 
g
 
 for 90 min at 4
 
8
 
C to obtain the cytoplasmic frac-
tion. The pellet of the 100,000 
 
g
 
 spin was washed three times in homogeni-
zation buffer and resuspended in 150 
 
m
 
l of homogenization buffer to ob-
tain the membrane fraction. Protein in each fraction was determined
spectrophotometrically (Bradford, 1976). Equal amounts of protein (125
 
m
 
g) from each fraction were incubated with 4.25 
 
m
 
Ci 
 
l
 
-[methyl-
 
3
 
H]SAM
in a total volume of 50 
 
m
 
l for 1 h at 37
 
8
 
C. The labeling reaction was
stopped by adding 12.5 
 
m
 
l of 5
 
3
 
 SDS-PAGE sample buffer (0.3 M Tris-
HCl, pH 6.8, 45% glycerol, 1.4 M 2-mercaptoethanol, 10% SDS, 0.001%
bromophenol blue) and holding the samples in a boiling water bath for 5
min. In vitro–labeled proteins from the cell fractions were then analyzed
by 7.5–15% gradient SDS-PAGE as described below.
 
Gel Electrophoresis
 
Discontinuous SDS-PAGE (Laemmli, 1970) was performed with 19-cm
separating gels composed of polyacrylamide gradients of 6–12, 7.5–15, or
8.5–15%, depending upon the experiment. Gels were fixed, stained with
Coomassie blue, and then destained. Gels containing proteins labeled
with [
 
32
 
P]orthophosphate were dried and placed in contact with Kodak
XAR film to produce an autoradiographic image. Gels containing tritium-
labeled proteins were prepared for fluorography by washing the gel for 1 h
in three changes of deionized water, followed by immersion in 1 M sodium
salicylate for 30 min (Chamberlain, 1979). After drying, the gels were ex-
posed to preflashed Kodak XAR film (Laskey and Mills, 1975) and stored
at 
 
2
 
70
 
8
 
C (Bonner and Laskey, 1974) with an intensifying screen. Quanti-
tative comparisons of methyl-labeled proteins were obtained by scanning
fluorograms into an analysis program (Molecular Analyst; Bio Rad Labo-
ratories, Hercules, CA).
For 2D IEF 
 
3 
 
SDS-PAGE, PC12 cell proteins were labeled as de-
scribed above and harvested in a lysis buffer appropriate for IEF (Aletta
and Greene, 1987). Equal TCA-precipitable counts per minute of cell ly-
sates were subjected to IEF with pH 5–7, and 3.5–10 ampholines at a ratio
of 4:1, respectively. Proteins in IEF gels were further resolved by SDS-
PAGE (the second-dimension) using 12-cm separating gels composed of
7.5–15% polyacrylamide gradient. A standard IEF gel containing only ly-
sis solution was used to determine the pH range. Fluorographic images of
tritium-labeled proteins were generated as described above.
 
DNA Methylation
 
Total methylation of cytosines in DNA was determined by first digesting
PC12 cell DNA with MspI, which cleaves methylated or unmethylated
CCGG sequences (Bestor et al., 1984). The products are 5
 
9
 
 labeled with
[
 
32
 
P]ATP, and digested with nuclease P1. Methyl-cytosines are resolved
from unmethylated cytosines by chromatography in isobutyric acid/water/
ammonium hydroxide (66:33:1) and detected by autoradiography (Bestor
et al., 1984). Liquid scintillation spectrometry was used to quantify the re-
sults.
 
Immunoprecipitation
 
Tyrosine phosphorylation of Trk in the presence or absence of DHCA
was assessed by immunoprecipitation followed by Western blotting. Cells
were treated with 100 ng/ml NGF for 5 min, with or without 1 
 
m
 
M DHCA.
Cells were then washed three times in ice-cold PBS and harvested in 1 ml
of a lysis buffer containing 1% Triton X-100, 150 mM NaCl, 50 mM Tris-
HCl, pH 8.0, 25 mM NaF, 5 mM EGTA, 5 mM EDTA, 2 
 
m
 
M PMSF, and
100 U/ml aprotinin. Insoluble material was removed by centrifugation at
4
 
8
 
C for 10 min at 13,000 
 
g.
 
 Samples were precleared with 6 mg PAS for 2 h
followed by centrifugation for 10 min at 13,000 
 
g.
 
 Anti-phosphotyrosine
monoclonal antibody (clone PT-66) was added to equal amounts of lysate
protein for 2 h on a rotating platform at 4
 
8
 
C followed by addition of 3 mg
of PAS and incubation on the rotating platform at 4
 
8
 
C for 1 h. PAS beads
were then recovered by centrifugation at 13,000 
 
g
 
 for 10 min, and washed
three times with 1 ml of 1% Triton X-100 lysis buffer followed by two 1-ml
washes in lysis buffer without Triton X-100. The PAS beads were then re-
suspended in SDS-PAGE sample buffer and held in a boiling water bath
for 5 min. The precipitated material was resolved by SDS-PAGE (7.5%
acrylamide) followed by transfer to Immobilon P membrane (Millipore
Corp., Milford, MA). The blot was probed with 1 
 
m
 
g of rabbit polyclonal
Trk antiserum (Santa Cruz Biotechnology, Santa Cruz, CA) for 2 h at
room temperature followed by incubation with 
 
125
 
I-donkey anti–rabbit
IgG. The dried blot was then exposed to Kodak XAR film at 
 
2
 
70
 
8
 
C with
an intensifying screen.
 
SAHH Activity
 
PC12 cells were plated on 150-mm dishes (2 
 
3
 
 10
 
7
 
 cells) in the presence of
100 ng/ml NGF plus 10 nM to 3 
 
m
 
M DHCA, or without added DHCA for
7 d. Cells were then washed three times in ice-cold PBS and harvested by
scraping in a potassium phosphate buffer, pH 7.0 (25 mM KH
 
2
 
PO
 
4
 
, 25
mM K
 
2
 
HPO
 
4
 
, 1 mM dithiothreitol, 0.5 
 
m
 
M PMSF, and 10 
 
m
 
g/ml leupep-
tin). Cells were homogenized in a Dounce homogenizer, and the cell nu-
clei and debris were removed by centrifugation at 13,000 
 
g.
 
 Cytosol was
then prepared by centrifugation at 100,000 
 
g
 
 for 90 min and the protein
concentration determined. SAHH activity was determined in the synthesis
direction by a TLC method described previously by Hershfield (1979).
 
Results
 
NGF-specific Induction of Changes in the Pattern of 
PC12 Cell Methylated Proteins
 
Previous studies have implicated regulation of protein
methylation in the early events of NGF-mediated signal
transduction (Seeley et al., 1984; Kujubu et al., 1993). To
examine this possibility in greater detail, protein methyla-
tion patterns were assessed after metabolic radiolabeling
of cellular proteins with 
 
l
 
-[methyl-
 
3
 
H]methionine. Fluoro-
grams of the labeled proteins generated from SDS-PAGE
and 2D IEF 
 
3
 
 SDS-PAGE were used to detect specific
changes in protein methylation after NGF treatment. The
cellular pool of SAM, the predominant methyl donor in all
cells, was radiolabeled using 
 
l
 
-[methyl-
 
3
 
H]methionine in
control PC12 cells, and PC12 cells treated with either 50
ng/ml NGF, 5 nM EGF or 1 
 
m
 
M insulin. These concentra-
tions and growth factors were chosen based on the biologi-
cal effects produced by each in PC12 cells. NGF at 50 ng/
ml produces the maximum neurite outgrowth response.
EGF at 5 nM enhances cell proliferation (Huff et al., 1981)
and 1 
 
m
 
M insulin is commonly used to effect cell survival
in serum-free media (Rukenstein et al., 1991). We have
verified that receptors for all three of these growth factors
are present on the PC12 cells used in these studies, by ob- 
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servation of the aforementioned biological effects at the
doses indicated (data not shown). Radiolabeled methio-
nine equilibrates with the cellular SAM pool within 20 min
(Chelsky et al., 1985). A protein synthesis inhibitor, aniso-
mycin (10 
 
m
 
M), was present during the metabolic radiola-
beling to prevent incorporation of 
 
l
 
-[methyl-
 
3
 
H]methio-
nine into newly synthesized proteins.
In each of five independent trials, all three trophic fac-
tors produced a net increase in methyl group incorpora-
tion into PC12 cell protein. After 6 h of treatment, EGF
and insulin lead to 
 
z
 
50% greater incorporation (
 
6
 
0.2,
SEM) and NGF to a 31% increase (
 
6
 
0.1, SEM). Despite
the slightly larger effects of EGF- and insulin-promoted
increases in total methyl-
 
3
 
H–labeled protein, NGF treat-
ment consistently yields protein methylation patterns ex-
hibiting more pronounced changes in specific methylated
proteins (Fig. 1). Several, indistinctly resolved proteins
that migrated between 24 and 20 kD showed increased
methyl labeling relative to total protein methylation after
6 h NGF treatment (Fig. 1, 
 
top right
 
). Among the meth-
ylated species detected in control cell lysates, were nine
68–60-kD proteins with isoelectric point (pI) values of 5.8–6.4
(Fig. 1, 
 
A–G
 
, *, and 1). After treatment with 50 ng/ml
NGF for 6 h, the proteins labeled A, *, and 1 in Fig. 1
showed little or no reproducible changes in methylation
relative to controls. Although there was a net increase in
total protein methylation, both increases and decreases in
the methylations of specific proteins relative to total pro-
tein methylation were detected in response to NGF. De-
creased labeling of proteins B, D, and E was detected with
NGF (Fig. 1 b). Methyl labeling of proteins C, F, and G in-
creased markedly, and methyl group incorporation into
two proteins (N and N9) was detected only after 6 h in
NGF-treated cells, but not in controls (Fig. 1 b).
Significant NGF-induced effects on protein methylation
were also detected at pI 6.7–6.8 and 5.8–6.2 in the 50-kD
region (Fig. 1, a and b). Labeling of protein 3 was unaf-
fected by NGF. Decreased methyl labeling of protein 1
was detected after 6 h NGF treatment, while proteins 2, 4,
and 7 showed increased methyl labeling, and the [methyl-
3H] incorporation into protein 5 was only detected in
response to NGF. The effects of NGF on protein methyla-
tion are unlikely to be due to incorporation of l-[meth-
yl-3H]methionine into newly synthesized proteins because
protein synthesis was inhibited by 97 6 0.1% (n 5 3) un-
der the conditions of these experiments. In addition, no
significant increases or decreases in the amounts of the
specific proteins analyzed in Fig. 1 were detected by 2D
IEF 3 SDS-PAGE of [35S]methionine-labeled proteins in
whole cell lysates, in the absence of protein synthesis inhi-
bition (data not shown).
The NGF-induced changes in methyl labeling of specific
proteins were not observed with the two other trophic fac-
tors tested. After EGF treatment for 6 h, the methylation
pattern of the 68–60-kD proteins was quite different from
the NGF-induced changes relative to the control, nonstim-
ulated cells (Fig. 1). The pattern of protein methylations
with EGF was more similar to the pattern with control
cells, but small increases in the methylation of proteins in
this relative molecular weight range were reproducibly de-
tected (B, C, D, and E). NGF, on the other hand, de-
creased the methylation of proteins B, D, and E. The
changes in protein methylations were less marked with
EGF than NGF and no methylated protein was detected
with EGF that was not detected with controls. Moreover,
no significant effects of EGF were detected in the 50-kD
set of methylated proteins. Insulin had no significant ef-
fects on the methylation of the 68–60- or 50-kD proteins
(data not shown).
The effects of NGF on the pattern of protein methyla-
tion were also examined by in vitro labeling of proteins in
subcellular fractions from NGF-treated cells as an inde-
pendent approach for detecting the protein methylations
that are affected by NGF. In vitro labeling provides a com-
plementary method of analysis that does not require a pro-
tein synthesis inhibitor. It also indicates the possible cellu-
lar locations of protein methylation. PC12 cells were
incubated without or with NGF for 15 min, 6 or 16 h. Nu-
Figure 1. NGF induces specific changes in the pattern of in vivo
protein methylation observed by 2D IEF 3 SDS-PAGE. PC12 cell
proteins were metabolically labeled with l-[methyl-3H]methio-
nine (100 mCi/ml) in the presence of anisomycin (10 mM) for 6 h.
Whole cell lysates containing equal TCA-precipitable cpm
(800,000) were separated by IEF. IEF gels were loaded onto 8.5–
15% gradient gels for the separation of methylated proteins by
molecular mass. Fluorographic images generated from the con-
trol and 6 h NGF (50 ng/ml) conditions are illustrated in the top
two panels. Molecular mass standards (in kD) are indicated at the
left of each panel. The boxed area in the top panels is enlarged
below for control, 6 h NGF and 6 h EGF (5 nM) samples. Fluoro-
grams were generated by exposing x-ray film to the dried gels
with an enhancing screen for 10 d at 2708C. The pH gradient of
the isoelectric focusing tubes is shown below the enlarged images
(a–c). Labels (A, *, and 1) indicate unaffected methylations,
while the remaining letters and numbers indicate protein meth-
ylations affected by NGF. These results are representative of
three independent experiments.Cimato et al. Regulation of Protein Methylation by NGF 1093
clei (500 g), membranes (100,000 g, pellet), or cytosol
(100,000  g, supernatant) were isolated and incubated with
[methyl-3H]SAM for 1 h at 378C, in vitro. Methylated pro-
teins were resolved by 7.5–15% gradient gel SDS-PAGE
and detected by fluorography. Changes in protein methyl-
ation were detected in nuclei, membranes, and cytosol
(Fig. 2). Increases in protein methylation were detected af-
ter 15 min of NGF treatment (data not shown) and contin-
ued to increase from 6 to 16 h (Fig. 2 A). Moreover, sev-
eral of the proteins that showed increases in methylation
have similar molecular weights as those detected by 2D
IEF 3 SDS-PAGE (Fig. 1) after metabolic radiolabeling
of intact cells (e.g., 68–64 kD, and 50 kD). Thus, changes
in the methylation of proteins in response to NGF was
confirmed by two independent approaches. In the nuclear
fraction, time-dependent increases (more than twofold) in
protein methylation in response to NGF treatment were
detected in proteins migrating at 97, 94, 67, and 64 kD. In
the membrane fraction, the methylation of proteins mi-
grating at 50 and 34 kD decreased after 6 or 16 h of NGF.
Several proteins in the cytosolic fraction showed increased
methylation. Most prominent among these were 114, 94,
50, and 35 kD. Additional NGF-induced effects were ob-
served by the in vitro method. This is most likely due to
the higher specific activity of the [methyl-3H]SAM pool in
vitro than in the intact cell experiments and the enrich-
ment of proteins by subcellular fractionation. In addition,
the in vitro labeling experiments indicate that both the
requisite methyltransferase and protein substrate were
present at the time of analysis in each of the subcellular
fractions that were isolated from NGF-activated cells.
Moreover, irrespective of the specific mechanisms respon-
sible for activation of the methylation of specific proteins
by NGF, the state of activation was stable during prepara-
tion of the fractions.
To validate this approach further, cytosol was prepared
from cells treated with or without NGF after metabolic ra-
diolabeling, and replicate cultures without metabolic ra-
diolabeling were also processed to obtain cytosol for in
vitro protein methylation. Comparisons of the 2D IEF 3
SDS-PAGE fluorograms from each type of preparation
indicate that several of the same proteins resolved in the
64 kD range (pI 5.8–6.4) are similarly increased after
NGF treatment by either method of analysis (Fig. 2 B).
The in vitro data obtained after NGF treatment for 6 h
confirm that changes in protein methylation triggered by
NGF can occur whether or not protein synthesis has been
inhibited. Thus, the in vivo and in vitro experiments inde-
pendently indicate that NGF produces diverse, marked ef-
fects on the regulation of the methylation of several spe-
cific proteins.
NGF Affects Protein Methylation during Early and 
Delayed Signaling
The time dependence of NGF-induced changes in protein
methylation was examined to determine the onsets and
durations of changes in protein methylation. PC12 cells
were incubated with NGF for 15 min to 24 h to examine
protein methylation during early stages of NGF signaling
and for 4 d to examine changes occurring concurrently
with the appearance of neurites. Total protein methylation
Figure 2. NGF-treatment of intact cells stimulates in vitro pro-
tein methylation in cell-free extracts. (A) PC12 cells were incu-
bated in the presence or absence of NGF (50 ng/ml) for 6 or 16 h.
Proteins in the nuclear (500 g, pellet), membrane (100,000 g, pel-
let), or cytosolic (100,000 g, supernatant) fractions were radiola-
beled with l-[methyl-3H]SAM for 1 h at 378C. The labeling reac-
tion was quenched by the addition of 53 SDS-PAGE sample
buffer followed by holding the reaction tube in a boiling water
bath for 5 min. Labeled proteins were separated by 7.5–15% gra-
dient SDS-PAGE. The image shown is a fluorogram of the dried
gel. Asterisks indicate methylated proteins not detectable in ex-
tracts from non-NGF-treated control cells. Arrows identify in-
creases of 67% or greater. The arrowheads (membrane fraction)
point out decreases of .30%. These results were reproduced in
an independent experiment. Specific changes at 16 h were as fol-
lows: nuclear proteins at 97 and 64 kD increase 2.4-fold; cytosolic
proteins at 50 kD and 35 kD increase 67 and 79%, respectively.
(B) Cell proteins were metabolically radiolabeled followed by
preparation of cytosol (in vivo) or the cytosol was prepared first,
followed by incubation with [methyl-3H]SAM (in vitro). A por-
tion of the 2D IEF 3 SDS-PAGE fluorograms from control
(2NGF) versus 6 h NGF treatment (1NGF) are displayed.
There are five individual protein spots migrating at 64 kD, which
are most easily discerned in the in vivo 1NGF condition. The
64-kD series of spots in each of the other fluorograms (four spots
each) are superimposable with those of the in vivo 1NGF condi-
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was assessed by the incorporation of [3H]methyl groups
into TCA-precipitable protein during NGF treatment for
24 h (Fig. 3). Significant increases in the total amounts of
methyl group incorporation were detected within 15 min
after the addition of NGF. The response over the early
time course is biphasic with an initial rapid burst of methy-
lation that decays between 1 and 4 h of NGF treatment
followed by a second, persistent phase of elevated meth-
ylation from 6 to 24 h. The pronounced decrease in methyl
group incorporation between 1 and 4 h indicates that the
effect of NGF on total protein methylation is likely to be
complex and dependent upon multiple factors, including
methionine uptake, intracellular compartmentalization,
and use of the labeled methyl group in other metabolic
pathways. Thus, all comparisons of protein methylation
patterns examined by gel electrophoresis were standard-
ized relative to total methyl-3H–labeled protein.
Although the resolution of changes in protein methyla-
tion in whole cell lysates is reduced on one dimensional
SDS-PAGE gels, this method was used to observe the
time course of changes in the set of proteins migrating at
64–62 kD. Gradient SDS-PAGE and fluorographic analy-
sis of methyl-3H–labeled proteins in whole cell lysates in-
dicated that there are increases in the methylation of the
proteins in this region of the gel, detectable within 1 h af-
ter the addition of NGF and persisting for at least 8 h (Fig.
4 A). In addition, when using an 8.5–15% acrylamide gra-
dient, a reproducible NGF-specific change in a 34-kD pro-
tein is evident at 3 and 6 h of NGF treatment (Fig. 4 B),
but not at times earlier than 2 h (data not shown).
To determine if any of the changes in methyl group in-
corporation persist for several days, the labeling studies
were repeated in PC12 cells treated with NGF for 4 d. This
time point was chosen because z50% of PC12 cells have
neurites >20-mm long after 4 d of NGF (Greene et al.,
1982). In addition, it was reasoned that some protein
methylations may occur during neurite outgrowth that
were not detected during early stages of NGF action.
Thus, after 4 d of NGF, methylated proteins were ana-
lyzed by metabolic radiolabeling of cell proteins followed
by 2D IEF 3 SDS-PAGE (Fig. 5) as described above. The
pattern of [3H]methyl incorporation into PC12 cell pro-
teins relative to total methylated protein indicates that
many of the changes induced by 6 h of NGF (Fig. 1) persist
for several days. Moreover, several of the NGF-induced
increases and decreases in protein methylation observed
after 6 h of NGF treatment were greater after 4 d of NGF
treatment. Methylation of proteins between 68 and 60 kD
(C, F, G, N, and N9) and in the 55–50 kD region (2–4, 6,
and 7) increased relative to both the control (Fig. 5) and
the 6 h NGF result (Fig. 1). Proteins C, F, G, N, and N9 ap-
pear to be the same proteins (based on pI and Mr) that
showed increases in methylation after 6 h of NGF treat-
ment. Also, after 4 d of NGF treatment, the methylation of
proteins B, D, and E, as well as protein 1 in the 50-kD re-
gion decreased relative to the control or 6-h NGF result. A
Figure 3. The time dependence of total methyl group incorpora-
tion into proteins in response to NGF. PC12 cell proteins were
metabolically labeled with l-[methyl-3H]methionine (100 mCi/
ml) for 6 h in the presence of anisomycin (10 mM). NGF (50 ng/
ml) was added to the cell cultures for the times indicated. Cells
were lysed in SDS-PAGE sample buffer. Total methyl labeling of
proteins (counts per minute) was measured for each condition af-
ter TCA precipitation of an aliquot of the sample. The relative
amount of the 3H-labeled methyl groups in lysate proteins at each
time point is given with respect to nontreated control cells. The
data shown are the means 6 SEM for five independent experi-
ments.
Figure 4. Changes in the pat-
tern of protein methylation
are NGF specific and time
dependent. (A) PC12 cell
proteins were metabolically
labeled with l-[methyl-3H]me-
thionine (100 mCi/ml) for 6 h
in the presence of anisomy-
cin (10 mM) with or without
NGF (50 ng/ml) for the times
indicated. Whole cell lysates
containing equal TCA-pre-
cipitable cpm (300,000) were
loaded in each lane. Proteins
were separated by 7.5–15%
gradient SDS-PAGE. The
image shown is a fluorogram
of the dried gel after expo-
sure to x-ray film for 3 d at
2708C with an intensifying
screen. The bracket indicates
the migration position of a
64–62-kD complex of proteins
that increase in a time-depen-
dent manner. The arrowhead
indicates the migration posi-
tion of an invariant protein
band, the density of which does not change by more than a few
percent over the time course. By this measure, the 4-h lane is
slightly overloaded, and the 6-h lane, underloaded. Nevertheless,
the change in the 64–62-kD protein complex is still evident in the
latter. The results illustrated here are representative of five inde-
pendent experiments. (B) Metabolically radiolabeled methylated
proteins (300,000 cpm) were obtained as described above and
loaded on 8.5–15% polyacrylamide gradient gels to more favor-
ably resolve the area between 29 and 36 kD. The image shown is
a fluorogram derived from the dried gel after exposure to x-ray
film for 2 d at 2708C. The arrow indicates the migration position
of a regulated 34-kD protein. Cultures were treated with NGF
(50 ng/ml), EGF (5 nM), or insulin (1 mM). The results shown are
representative of three independent experiments.Cimato et al. Regulation of Protein Methylation by NGF 1095
number of novel methylated proteins were also observed
after 4 d of NGF treatment that were not detected after
6 h. These include proteins B9, C9 in the 60-kD region of
the gel, and proteins 79, 799, 8, and 9, appearing in the 50-
kD region of the gel. The distinctly different time courses
for the methylations of specific proteins suggest that NGF
may regulate the methylation of proteins involved in mul-
tiple signaling pathways. Moreover, most of the NGF-
dependent changes in methylated proteins that were de-
tected are not associated with transient phenomena.
Inhibition of Methylation Inhibits Neurite Outgrowth
The marked effects of NGF on the methylation of specific
proteins calls attention to the possibility that protein
methylation is required for NGF signal transduction and
neurite outgrowth. This possibility was examined by ob-
serving NGF-mediated neurite outgrowth after inhibiting
methylation using two approaches based on the biochemi-
cal pathway outlined in Fig. 6. One approach was inhibi-
tion of SAHH by a mechanism-based, substrate analogue
inhibitor, DHCA (Liu et al., 1992). SAHH catalyzes the
reversible hydrolysis of SAHcy to homocysteine and aden-
osine by an NAD-dependent mechanism (De la Haba and
Cantoni, 1959; Liu et al., 1992). The reaction is driven in
the hydrolysis direction in vivo by the adenosine deami-
nase–catalyzed conversion of adenosine to inosine. DHCA
blocks the methylation pathway by inhibiting SAHH.
Like the normal substrate, SAHcy, DHCA is oxidized
by SAHH coupled to NAD1 reduction, but the 3-keto
DHCA formed cannot be hydrolyzed, thereby trapping
SAHH in its inactive, NADH form (Liu et al., 1992).
SAHH inhibition results in an accumulation of its sub-
strate, SAHcy, a potent competitive inhibitor of methyl-
transferases (Hildeshein et al., 1972).
The concentration dependence for inhibition of neurite
outgrowth by DHCA (Fig. 7 A) was determined by incu-
bating PC12 cells with NGF for 7 d with or without 10 nM
to 3 mM DHCA. Neurite outgrowth was scored after 7 d of
NGF treatment as described under Materials and Meth-
ods. The concentration of DHCA required to inhibit neu-
rite outgrowth by 50% was z100 nM. A second approach
that was used to test for a requirement of protein meth-
ylation in neurite outgrowth was inhibition of SAHH by
addition of extracellular homocysteine, alone or in combi-
nation with DHCA. When intracellular levels of homocys-
teine rise, the SAHH-catalyzed reaction is driven in the
synthesis direction (De la Haba and Cantoni, 1959; Ha-
sobe et al., 1989), i.e., towards the formation of SAHcy
(Fig. 6). Excess homocysteine acts cooperatively with in-
hibitors of SAHH in many other cell types (Chiang et al.,
1977; Kredich and Martin, 1977; Backlund et al., 1986; Ha-
sobe et al., 1989), and the combination of the two is ex-
pected to elicit more inhibition of methylation than either
alone. As shown in Fig. 7 B, 100 nM DHCA reduced
NGF-induced neurite outgrowth to 59% of control (NGF
alone), and 100 mM homocysteine reduced NGF-induced
neurite outgrowth to 42%. The combination of 100 nM
DHCA plus 100 mM homocysteine inhibited the neurite
outgrowth by more than 80%. The findings that homocys-
teine alone inhibits neurite outgrowth, and that homocys-
teine enhances the inhibitory effect of a low dose of
DHCA on neurite outgrowth indicate that the effect of
DHCA on neurite outgrowth is most likely due to inhibi-
tion of methylation.
Fig. 8 illustrates the effects of DHCA or DHCA plus
homocysteine on cell morphology observed by phase con-
trast microscopy of NGF-treated PC12 cells. After 7 d of
NGF-treatment, PC12 cells flatten, hypertrophy, and elab-
orate long neurites (Fig. 8 B). In the presence of 1 mM
DHCA and NGF for 7 d, the cells continue to respond to
NGF by flattening, but neurite outgrowth is greatly atten-
uated (Fig. 8 C). Short, spike-like processes are observed.
Figure 5. NGF-induced changes in protein methylation persist
and progress during prolonged NGF treatment. PC12 cells were
incubated with or without NGF (50 ng/ml) for 4 d. Cells were la-
beled with l-[methyl-3H]methionine (100 mCi/ml) in the presence
of anisomycin (10 mM) for 6 h. Equal TCA-precipitable cpm
(750,000) of cell lysates were subjected to IEF. IEF gels were
loaded on 7.5–15% gradient SDS-PAGE gels to separate meth-
ylated proteins by molecular mass. The images shown are fluoro-
grams of the dried gels after exposure of x-ray film for 12 d at
2708C with an intensifying screen. The areas of the gels shown
are similar to the boxed areas shown in Fig. 1. The pH gradient of
the IEF gels is indicated at the top of the figure. Labels are as in
Fig. 1.
Figure 6. The methylation
pathway. SAHH catalyzes
the reversible hydrolysis of
SAHcy. Inhibition of SAHH
by DHCA or homocysteine
leads to an accumulation of
SAHcy and inhibition of
methyltransferases.The Journal of Cell Biology, Volume 138, 1997 1096
In the presence of 100 nM DHCA plus 100 mM homocys-
teine, the cells appear more flattened than control cells,
but little neurite outgrowth is observed (Fig. 8 D). Thus,
inhibition of methylation by DHCA, homocysteine, or the
cooperative action of the two together suggest that meth-
ylation is an important requirement for NGF-induced neu-
rite outgrowth. In addition, the morphological evidence
(Fig. 8) indicates that not all NGF actions (e.g., the cell-
flattening response) are inhibited by factors that inhibit
methylation (see below).
DHCA-induced inhibition of SAHH was verified by di-
rect measurement of SAHH activity. DHCA at 1 nM pro-
duced 70% inhibition and .90% inhibition was achieved
at 10 nM. The consequence of this inhibition (elevated intra-
cellular level of SAHcy) is expected to inhibit protein meth-
ylation (Fig. 6). Thus, the effect of DHCA on protein meth-
ylation was directly determined by assessing protein
methylation in PC12 cells using metabolic radiolabeling
with l-[methyl-3H]methionine in the presence of anisomy-
cin. The dose-dependent inhibition of protein methylation
observed is similar to that of the DHCA effect on neurite
outgrowth (Fig. 9). DHCA (1 mM) inhibits total methyl
group incorporation measured by TCA-precipitation of
equal aliquots of whole cell lysates as described under Ma-
terials and Methods. The total reduction in radiolabeled,
methylated protein was 40% in control, non-NGF-treated
cells, and 52% in cells stimulated with NGF for 6 h. Simi-
lar differences in the inhibitory effects (6NGF) were ob-
served at all doses of DHCA above 30 nM (data not
shown). The inhibitory action of DHCA is thus greater in
NGF-treated cells. In conclusion, these experiments indi-
cate that protein methylation is markedly inhibited by
DHCA at concentrations that inhibit neurite outgrowth.
In contrast, neither NGF alone nor DHCA with or with-
out NGF have a significant effect on total methylation of
cytosines in PC12 cell DNA. The percentage of total cy-
tosines methylated in NGF-treated cells (53.3 6 1.5) ver-
sus that in cells treated with NGF plus DHCA (48.1 6 0.2)
was not statistically significant (n 5 3, Student’s paired t
test; P . 0.05, two tails). All measurements were per-
formed after 24-h treatments.
DHCA Treatment Does Not Interfere with Cell 
Proliferation or Early NGF-mediated Signaling Events
Previous efforts to examine the possible role of methyla-
tion in NGF signal transduction (Seely et al., 1984; Haklai
et al., 1993; Kujubu et al., 1993) used methylation inhibi-
tors at relatively high concentrations that can produce cy-
totoxicity (Seeley et al., 1984) and inhibition of receptor
tyrosine kinases (Meakin and Shooter, 1991; Maher 1993).
The methylation inhibitor used in this study, DHCA, is
much less toxic than the related adenosine analogues used
previously and is effective at concentrations four orders of
magnitude lower than those used previously (Seeley et al.,
1984; Meakin and Shooter, 1991; Haklai et al., 1993; Ku-
jubu et al., 1993; Maher, 1993). DHCA does not affect the
growth rate of PC12 cells in serum-containing medium
(Fig. 10 A). In the absence of serum, PC12 cells degener-
ate via programmed cell death. DHCA has no effect on
the rate that cell death is induced (Fig. 10 A). In the ab-
sence of serum, NGF rescues PC12 cells from programmed
cell death (Rukenstein et al., 1991). Also shown in Fig. 10
A, DHCA had no effect on the protection afforded by
NGF. In addition to confirming the absence of cytotoxic-
ity, these findings suggest that DHCA does not interfere
with the ability of NGF to activate its tyrosine kinase
receptor (Trk), which prevents programmed cell death
Figure 7. Concentration-dependent inhibition of neurite out-
growth by inhibitors of methylation. (A) Effect of DHCA. PC12
cells on 35-mm collagen-coated tissue culture dishes (300,000
cells per dish) were treated with NGF (50 ng/ml), or NGF and
DHCA (10 nM to 3 mM) for 7 d. Neurite-bearing cells were
scored as described under Materials and Methods. Cultures
treated with NGF and no DHCA received the DMSO vehicle
only, which had no effect on neurite outgrowth. The line was fit
by least squares regression analysis. The data shown are the
means 6 SD for three independent experiments. (B) Effect of
homocysteine alone and in combination with DHCA. All cul-
tures were treated with NGF (50 ng/ml) and scored for the pres-
ence of neurites after 7 d. The data shown are the means 6 SD
for three independent experiments. The white bar represents the
NGF control condition without DHCA or homocysteine. Results
from cultures treated with 100 nM DHCA are represented by the
adjacent striped bar (DHCA), and those from cultures treated
with 100 mM homocysteine in the next striped bar (Hcy). The
cross-hatched bar indicates results from cultures treated with 100
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(Kaplan and Stephens, 1994). Thus DHCA has no detect-
able effects on the growth or survival of PC12 cells under
any of the conditions examined.
Since other adenosine-analogues, which are putative
methylation inhibitors, are known to inhibit phosphoryla-
tion and activation of Trk (Meakin and Shooter, 1991; Ma-
her 1993), the effect of DHCA on the tyrosine phosphory-
lation of Trk was also determined. PC12 cells were
incubated with or without 1 mM DHCA for 1 h, and NGF
was then added for 5 min. Immunoprecipitation with a
phosphotyrosine antibody was followed by SDS-PAGE
and immunoblotting with anti-Trk antibody. DHCA had
no detectable effect on the Trk tyrosine phosphorylation
mediated by NGF (Fig. 10 B), the primary event in NGF
signaling.
To determine if DHCA affects other phosphorylation
events downstream of Trk activation, total phosphopro-
teins were analyzed by SDS-PAGE. Several NGF-induced
increases in phosphorylation of proteins are resolved by
this method (Fig. 10 C). The rapid increase in the phos-
phorylation of tyrosine hydroxylase (Halegoua and Pat-
rick, 1980) that occurs after NGF treatment is not affected
by DHCA. The overall phosphorylation pattern was simi-
larly unaffected by DHCA. Two other NGF-induced in-
creases in phosphorylation, which require long-term (7 d)
NGF treatment, are temporally associated with neurite
outgrowth. Unlike phosphorylation of tyrosine hydroxy-
lase, the increased 32P incorporation into the 64-kD char-
tin (Aletta and Greene, 1987) and b-tubulin (Aletta, 1996;
Black et al., 1986) is diminished by exposure of the cells to
DHCA. The inhibitory effect of DHCA on the phosphory-
lations of these two proteins is the predicted consequence
of DHCA inhibition of neurite outgrowth. Thus, DHCA
affects delayed phosphorylation events in NGF signaling
but does not inhibit phosphorylations associated with the
early signaling events studied here.
DHCA Effects on Neurite Outgrowth Are Diminished 
by prior NGF Treatment and Are Rapidly Reversible
To explore further the functional significance of the time
dependence of protein methylation during NGF-mediated
neurite outgrowth, DHCA (1 mM) was added to PC12
cells at the same time that NGF was added or 1–6 d after
Figure 8. The effects of DHCA and homocysteine on neurite outgrowth and cell morphology. PC12 cells were plated on 35-mm col-
lagen-coated tissue culture dishes at a density of 300,000 cells per dish. Cells were cultured for 7 d under control conditions without NGF
(A), with 50 ng/ml NGF (B), NGF plus 1 mM DHCA (C), or NGF with 100 nM DHCA and 100 mM homocysteine (D). Bar, 50 mm.The Journal of Cell Biology, Volume 138, 1997 1098
NGF addition. Under these conditions, the later DHCA
was added after NGF, the less its inhibitory effect (Fig. 11
A). The decrease in inhibition showed a linear dependence
on the time at which DHCA was added to the cells. Once
the NGF-signaling cascade begins, neurite outgrowth is
progressively less sensitive to inhibition of methylation.
This would occur if the rates of demethylation were low
for those methylated proteins that are required for neurite
outgrowth. Alternatively, neurite outgrowth may be insen-
sitive to inhibiting methylation once neurite outgrowth
proceeds past a critical, committed step. While initiation
of neurite outgrowth from PC12 cells after exposure to
NGF is slow (requiring 7 d to achieve z100% neurite
bearing cells), PC12 cells can rapidly regenerate after pre-
formed neurites are disrupted as described under Materi-
als and Methods. Fig. 11 B shows the concentration depen-
dence of inhibition of neurite regeneration by DHCA.
Neurite regeneration was inhibited 40% by 3 mM DHCA.
In contrast, if 3 mM DHCA is used when NGF is first
added to the cells, it inhibits neurite outgrowth by 84%
(Fig. 7 A). As described above, the difference in the sensi-
tivities of regeneration and de novo neurite outgrowth to
inhibition by DHCA is consistent with slow rates of de-
methylation or decreased sensitivity to DHCA once dif-
ferentiation has reached a critical stage.
The onset of neurite outgrowth after DHCA is removed
was examined to compare the rate of reversing the effect
of DHCA on neurite outgrowth to the rate of NGF-
induced neurite outgrowth when DHCA had never been
present. In addition, removal of DHCA was used to detect
protein methylations that are associated with neurite out-
growth during the reversal period. Reversibility of the ef-
fects of DHCA on neurite outgrowth and protein methyla-
tion was assessed by incubating PC12 cells with NGF and
DHCA for 10 d, followed by removal of the DHCA. Inter-
estingly, the inhibitory effect of DHCA on neurite out-
Figure 9. Dose-dependent effect of DHCA on total protein
methylation in PC12 cells correlates with the DHCA effect on in-
hibition of neurite outgrowth. Inhibition of NGF-stimulated neu-
rite outgrowth (j) by DHCA was compared to the inhibition of
total protein methylation (s) at the same doses of DHCA. PC12
cells were treated with DHCA (30 nM to 3 mM) and NGF (50 ng/
ml) for 6 h in the presence of anisomycin to determine total pro-
tein methylation as described under Materials and Methods. Inhi-
bition is plotted relative to control cultures treated with NGF
only. The neurite outgrowth data are replotted from Fig. 7 A.
Figure 10. DHCA treatment
does not interfere with cell
growth, NGF-mediated sur-
vival, or rapid onset NGF-
stimulated phosphorylations.
(A) PC12 cells were plated
on 24-well collagen-coated
dishes at a density of 100,000
cells per well. Cells were al-
lowed to attach to the dishes
overnight, and then were
washed with RPMI-1640 me-
dium to remove serum. Cells
were then cultured in com-
plete (serum-containing) me-
dium (CM, s and d), plus or
minus 1 mM DHCA; RPMI-
1640 without serum plus 50
ng/ml NGF, plus or minus 1
mM DHCA (NGF, h and j);
RPMI-1640 medium without
serum or NGF, plus or minus
1 mM DHCA (No serum, n
and m). Similar results were
observed in two other inde-
pendent experiments. (B) Ef-
fect on Trk phosphorylation.
PC12 cells were treated with
or without NGF (50 ng/ml)
for 5 min. Where indicated, 1
mM DHCA was added to
cultures for 1 h before treat-
ment with NGF. Cell lysates were equalized for total protein,
immunoprecipitated with anti-phosphotyrosine antibody (as de-
scribed under Materials and Methods), resolved by 7.5% SDS-
PAGE and transferred to Immobilon P membranes. The blot
was probed with anti-Trk antibody, followed by donkey anti–
rabbit 125I-IgG. The image shown is an autoradiogram of the
Western blot after a 5-d exposure at 2808C. This result was veri-
fied in a second independent experiment. (C) PC12 cells were
treated with or without NGF (50 ng/ml) for 2 h. DHCA (1 mM)
was added 1 h before the addition of NGF where indicated. Cells
were radiolabeled with [32P]orthophosphate for 2 h as described
under Materials and Methods. For long term NGF-induced
phosphorylations, PC12 cells were grown in the presence of NGF
(50 ng/ml) plus or minus 1 mM DHCA for 10 d. Cells were then
radiolabeled with [32P]orthophosphate for 2 h. For both short
and long term NGF treatment experiments, cell lysates were
equalized for total TCA-precipitable 32P-labeled protein and
separated on 6–12% gradient SDS-PAGE. The image shown is
an autoradiogram of the dried gel. Exposure time was 16 h. The
arrows at the right indicate, in decreasing Mr, the positions of the
previously identified phosphoproteins, 64-kD chartin, 60-kD ty-
rosine hydroxylase, and 55-kD b-tubulin.Cimato et al. Regulation of Protein Methylation by NGF 1099
growth was rapidly reversed (Fig. 12 A). No lag was ob-
served before an increase in neurite outgrowth was
detected. The t1/2 for reversal was 12 h (Fig. 12 A). The
rate of neurite outgrowth when DHCA is removed is,
therefore, about eightfold faster than the normal t1/2 for
neurite outgrowth when NGF is added to naive cells.
Thus, the NGF-dependent signaling events that prime the
cells (Burstein and Greene, 1978; Greene et al., 1982) for
neurite outgrowth were not inhibited greatly by the meth-
ylation inhibitor, DHCA.
Upon removal of DHCA, the rapid onset of neurite out-
growth was paralleled by rapid reversal of its inhibitory ef-
fects on the methylation of several proteins. Proteins that
increase by 25% or more in methylation upon removal of
DHCA are indicated by the arrows, brackets, and aster-
isks shown in Fig. 12 B. The molecular weights of proteins
that showed increased methylation migrate at 150, 120, 94,
70/68, 50, 48/47, 40, and 35 kD. The time dependencies for
methylation were different for different proteins. These
results, together with the time course (Figs. 4 and 5), inhib-
itor studies (Figs. 7–10), and specificity of the NGF-
induced effects on protein methylation (Fig. 1) indicate
that regulation of protein methylation is required for neu-
rite outgrowth.
Figure 11. The effect of prior
NGF treatment on the neurite
inhibiting action of DHCA.
(A) The effect of varying the
time interval between NGF
treatment and addition of
DHCA. PC12 cells were
treated with NGF (50 ng/ml)
for 7 d. DHCA (1 mM) was
added to the cells either at
the time NGF was initially
added to the cell cultures
(time zero), or after a time
interval of 1, 2, 3, 4, 5, or 6 d.
Cells were scored for the presence of neurites after 7 d of NGF. The data shown are the means 6 SD for three independent experi-
ments. (B) The effect of inhibition of methylation on neurite regeneration. PC12 cells were grown in NGF (50 ng/ml) for 7–14 d. NGF
was removed from the cultures by an extensive washing procedure described under Materials and Methods. Cells were removed from
the culture dishes by trituration and replated without or with DHCA (3 nM to 3 mM). NGF was added to all cultures 1 h after plating.
Neurite regeneration was scored 16–24 h later. The line was fit by least squares regression analysis. The data shown are the means 6 SD
for three independent experiments.
Figure 12. Reversal of
DHCA-induced inhibition of
methyltransferases results in
rapid neurite outgrowth and
a time-dependent increase in
protein methylation. (A) PC12
cells were plated on 35-mm
collagen-coated tissue culture
dishes at a density of 300,000
cells per dish in NGF (50 ng/
ml) plus or minus 1 mM
DHCA for 7 d. The medium
was then changed repeatedly
to remove DHCA, and neu-
rite outgrowth was scored
and plotted over a 3-d pe-
riod. Controls were main-
tained in DHCA/NGF (m)
and NGF alone (d). The ex-
perimental condition was
treatment with DHCA and
NGF for 7 d, followed by NGF alone for 3 d (j). The data are normalized to 100% relative to the number of neurite bearing cells
present in cultures treated with NGF alone. The data shown are the means 6 SD for three independent experiments. The line shown for
the reversal data is the best fit to a single exponential function with a t1/2 of 12 h. After DHCA removal, the protein methylation pattern
was also assessed by SDS-PAGE. (B) Cells were harvested after 10 d of DHCA/NGF treatment or after 7 d DHCA/NGF treatment fol-
lowed by progressively longer times (-h) in the absence of DHCA. Cell lysates were equalized for total TCA-precipitable 3H counts per
minute and separated on 7.5–15% gradient SDS-PAGE. The figure shown is a fluorogram of the dried gel. Exposure time was 5 d. The
arrows and brackets indicate the positions of proteins that increased in methylation by 25% or more relative to the 10 d DHCA lane.
Asterisks mark the position of protein bands not detected in the 10-d DHCA lane. The changes noted during the reversal period were
replicated in four independent experiments.The Journal of Cell Biology, Volume 138, 1997 1100
Discussion
The Subset of Methylated Proteins that
Are NGF-regulated
This work extends previous studies (Seeley et al., 1984;
Kujubu et al., 1993) of the role of methylation in growth
factor signaling mechanisms and further demonstrates the
feasibility of exploring this role by metabolic radiolabeling
of specific proteins in intact cells and by in vitro labeling of
proteins in cell fractions. The results indicate that protein
methylation is involved in the NGF-induced signal trans-
duction that leads to neurite outgrowth. Methylation of
numerous proteins was detected by metabolic radiolabel-
ing indicating that protein methylation is an ongoing, ac-
tive process. NGF specifically affects the methylation of a
subset of these proteins. Further evidence for a significant
role for protein methylation in neurite outgrowth is the
marked concurrent inhibitory effects of DHCA on protein
methylation and neurite outgrowth. Moreover, removal of
DHCA rapidly leads to concomitant increases in protein
methylation and neurite outgrowth. The identities and
functions of the NGF-regulated proteins remain to be de-
termined. It is likely that some of the proteins identified by
this approach represent previously unidentified players in
NGF signal transduction. This is significant because spe-
cific protein modifications that are temporally coincident
with neuronal differentiation may be useful in the elucida-
tion of the mechanism of action of NGF (Chao, 1992;
Kaplan and Stephens, 1994). Thus, signal transduction
pathways may be regulated in part by regulating the meth-
ylation of specific proteins in much the same manner as
protein phosphorylation regulates signaling pathways.
Potential Actions of Protein Methylation During NGF 
Signal Transduction
The data presented here focus on NGF actions on protein
methylations rather than methylation of phospholipids,
RNA or DNA. Methylation of genes serves as a general
signal for repression of transcription (Razin and Cedar,
1991). Hypomethylation of the genome is associated with
cellular differentiation in vitro (Bestor et al., 1984). There
were no significant effects of NGF and/or DHCA on total
DNA cytosine methylation in PC12 cells. Thus, the potent
inhibitory action of DHCA on neurite outgrowth is un-
likely to be due to an effect on DNA methylation. Previ-
ous work also indicates that NGF does not detectably af-
fect phospholipid methylation (Ferrari and Greene, 1985).
These authors further demonstrated that complete inhibi-
tion of phospholipid methylation is achieved at concentra-
tions of deaza-adenosine and homocysteine thiolactone
that do not block neurite outgrowth.
There are several potential mechanisms through which
NGF-induced changes in protein methylation may affect
biological responses. Gene regulation may be affected,
particularly if the modified proteins are involved in gene
expression. For example, many heterogeneous nuclear
RNPs that associate with pre-mRNAs are methylated on
arginine residues (Liu and Dreyfuss, 1995). Modulation of
RNA splicing has been proposed as one potential target
for protein methylation in signal transduction (Lin et al.,
1996). Consistent with this view, a protein arginine meth-
yltransferase activity appears to be constitutively associ-
ated with the type I interferon receptor (Abramovich et
al., 1997). A role for protein methylation in cell signaling is
further substantiated by the finding that methylation of
the g subunit of a heterotrimeric G-protein enhances acti-
vation of PI-specific phospholipase C and PI3-kinase in
vitro (Parish et al., 1995). If this biochemical effect occurs
in intact cells, protein methylation could play an important
general role in the amplification of intracellular signals.
Protein methylation may also be involved in altering the
subcellular localization of specific proteins, as recently
suggested for the cell cycle–dependent methylation of pro-
tein phosphatase 2A (Turowski et al., 1995).
Neurite outgrowth requires a fundamental reorganiza-
tion of the cytoskeleton including formation of intermedi-
ate filaments and parallel bundles of microtubules ori-
ented longitudinally in neurites, as well as specialized actin
microfilament arrays within motile growth cones. Inhibi-
tion of neurite outgrowth by DHCA may be related to in-
hibition of protein methylation, which affects the cyto-
skeleton. For example, Ras and Rho proteins, modified by
isoprenylation and methylation, are involved in redistribu-
tion of actin microfilaments during changes in cell shape
(Vojtek and Cooper, 1995). Recently, Luo et al. (1996)
presented evidence that constitutively active Rac1 in trans-
genic mice interferes with the normal formation of Pur-
kinje cell axons and dendrites. Since only the methylation
step of small G-protein processing is reversible (Rando,
1996), methylation is more likely than other processing
steps to be subject to physiological regulation. NGF-
induced increased methyl labeling of G-proteins in PC12
cells (Haklai et al., 1993; Kujubu et al., 1993) and the spe-
cific proteins observed in this study indicate that NGF may
serve as one mediator of regulatory control in responsive
neurons. Furthermore, Klein and colleagues have raised
the possibility that protein methylation plays an important
role in neurulation (Coelho and Klein, 1990; Moephuli et
al., 1997) and neurite outgrowth in rat embryo cultures
(Coelho and Klein, 1990). The present work lends addi-
tional support to this possibility, especially with regard to
neurite outgrowth.
DHCA Is a Potent and Nontoxic Inhibitor of
Protein Methylation
DHCA is a promising tool for investigating the possible
roles of methylation in signal transduction mechanisms.
This inhibitor was developed by Liu and colleagues to ob-
tain a more specific, less toxic inhibitor of SAHH than pre-
viously used inhibitors (Liu et al., 1992). The 50% effec-
tive dosage (ED50) for the effect of DHCA on neurite
outgrowth for PC12 cells (z100 nM) is four orders of mag-
nitude lower than previously used inhibitors (Seeley et al.,
1984). Inhibition of neurite outgrowth by .z85% is diffi-
cult to achieve, even at the highest concentration of the in-
hibitor. Pretreatment of cells with DHCA for several
weeks before NGF stimulation, however, does produce
nearly complete inhibition even at 7 d of NGF (Cimato,
T.R., M.J. Ettinger, and J.M. Aletta, unpublished obser-
vations). These observations provisionally indicate that
basal, ongoing protein methylation may serve an auxiliary
role in neurite outgrowth in addition to the NGF effectsCimato et al. Regulation of Protein Methylation by NGF 1101
on protein methylation. As expected, DHCA potently in-
hibits SAHH activity (Hasobe et al., 1989) and conse-
quently leads to decreased total protein methylation. The
dose-dependent inhibition of protein methylation ob-
served is quite similar to that for inhibition of neurite out-
growth (Fig. 9). The cooperative effects of homocysteine
and DHCA on neurite outgrowth further substantiate a
specific effect on methylation. The finding that total pro-
tein methylation was inhibited more when NGF was
present than when absent, suggests that under the influ-
ence of NGF, many of the potential methyltransferases in-
volved in the NGF response may be more sensitive to inhi-
bition due to increased levels of SAHcy. This may occur
because, as a result of increased total protein methylation
(Fig. 3), intracellular levels of SAHcy are expected to be
elevated even before DHCA treatment. NGF has no mea-
sureable effect on SAHH activity (Cimato, T.R., M.J. Et-
tinger, and J.M. Aletta, unpublished results).
DHCA is unique among methylation inhibitors because
of its lack of effect on cell flattening, phosphorylation of
tyrosine hydroxylase, and tyrosine phosphorylation of
Trk. Less specific methylation inhibitors, used to study the
role of methylation in PC12 cells previously (Seeley et al.,
1986; Kujubu et al., 1993; Maher, 1993; Meakin and
Shooter, 1995), blocked each of these actions. The most
remarkable property of DHCA in comparison to previ-
ously used inhibitors is that DHCA inhibits neurite out-
growth without inhibiting the NGF priming that prepares
PC12 cells for neurite outgrowth (Greene et al., 1982).
This is best illustrated by the rapid reversal of DHCA ef-
fects on neurite outgrowth, which is in marked contrast to
that observed with other methylation inhibitors. Reversal
of inhibition by 59-deoxy-S-methyl adenosine requires the
same 7 d as required by control PC12 cells when first ex-
posed to NGF (Seeley et al., 1986). Thus, DHCA is clearly
more specific than previously used methylation inhibitors.
DHCA specifically affects neurite outgrowth without af-
fecting many other signaling effects of NGF, including
those associated with priming.
Protein Methylation in Early and Delayed
NGF Signaling
Growth factors in general, promote biological responses
that are either extremely rapid (within minutes) or require
many hours or days to develop fully. The diversity of sig-
naling networks (Pawson, 1985; Hunter, 1995) and the
propensity of specific pathways to transmit and/or sustain
a given signal (Marshall, 1995) may help to explain the dif-
ferent temporal characteristics of responses. The results of
this study and other recent work (Metz et al., 1993; Philips
et al., 1993, 1995) indicate that posttranslational modifica-
tion of proteins by methylation offers another potential
mechanism for regulating both early and delayed growth
factor signaling.
The importance of early and delayed responses to NGF
in PC12 cells, dorsal root ganglion, and sympathetic neu-
rons is well documented (Greene, 1984). One of the most
obvious examples of a delayed NGF response is neurite
outgrowth. Little neurite outgrowth is evident in PC12
cells treated with NGF for 12–24 h. 50% of the cells extend
neurites within 4 d, and nearly all have neurites by 7 d.
NGF-mediated neurite outgrowth requires transcription
(Burstein and Greene, 1978; Greene et al., 1982). The long
latency is apparently due to the progressive accumulation
of specific proteins required for neurite assembly during
the priming period. This accumulation may depend on
protein synthesis (Burstein and Greene, 1978) and/or pro-
gressive posttranslational modifications of specific pro-
teins (e.g., as shown here for the methylation of specific
proteins). Since regeneration of neurites from PC12 cells
previously treated with NGF occurs much more rapidly
(within 24 h) than initiation (7 d); the longer time required
for neurite outgrowth in the latter is thought to be due to
the “priming” events.
When interpreted in light of the priming model of NGF-
induced neurite outgrowth, the experiments that used
DHCA provide important insights regarding the temporal
nature of protein methylation involved in this NGF re-
sponse. Inhibition of protein methylation by DHCA is
most effective in reducing neurite formation when the
DHCA is present concomitantly with NGF treatment.
There is decreased inhibition of neurite outgrowth as the
time interval between NGF treatment and the addition of
DHCA increases (Fig. 11 A). DHCA is also less effective
at inhibiting neurite regeneration (Fig. 11 B). These re-
sults imply progressive accumulation of the methylated
protein product(s) necessary for neurite outgrowth, as was
detected at 4 d of NGF treatment (Fig. 5). Slow turnover
of methylated proteins is consistent with the reduced ef-
fect of DHCA when added after NGF signaling has been
initiated.
The time dependencies of specific protein methylations,
the effects of DHCA on protein methylation, and the lack
of effects of DHCA on early protein phosphorylations and
priming are consistent with little or no interdependence
between protein methylation signaling events and early,
priming events. Moreover, the data presented on the phos-
phorylation of Trk and other proteins that lie downstream
of Trk activation (Fig. 10, B and C) further substantiate
the view that some cellular signaling events are more sus-
ceptible to interference from inhibition of protein methy-
lation than others. Autophosphorylation of Trk and the
rapid increase in the phosphorylation of tyrosine hydroxy-
lase (Halegoua and Patrick, 1980) are not affected by
DHCA. Two other NGF-induced increases in phosphory-
lation, which require long term (>7 d) NGF treatment for
maximal phosphorylation, are temporally associated with
neurite outgrowth. In accord with DHCA-mediated inhi-
bition of neurite outgrowth, but unlike the rapid, early
phosphorylation events, the increased 32P incorporation
into the 64-kD chartin (Aletta and Greene, 1987) and
b-tubulin (Black et al., 1986; Aletta, 1996) is diminished by
exposure of the cells to DHCA.
It can thus be concluded that DHCA does not disrupt all
early NGF signaling events and priming actions, nor does
it abrogate many of the biological effects of NGF signaling
(e.g., Fig. 10 A, survival; Fig. 9, cell flattening). The effects
of DHCA on neurite outgrowth and inhibition of the
phosphorylation of neurite-associated proteins (b-tubulin
and chartin) are consistent with a selective inhibitory ac-
tion on an NGF pathway responsible for neurite out-
growth. Based on all of the above results, the protein
methylation required is likely to occur downstream from,The Journal of Cell Biology, Volume 138, 1997 1102
or parallel to, rapid NGF actions and priming events. This
interpretation does not exclude the possibility that protein
methylation of rapid onset also plays an important role in
neurite outgrowth. Once priming is achieved, NGF stimu-
lation of some of the rapid protein methylations observed
in this study may assume added significance, particularly if
they occur at the growth cone.
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